hypertrophy

DEFINITION of hypertrophy

Hypertrophy is the enlargement of an organ or tissue caused by an increase in the size of its constituent cells, rather than an increase in their number. It distinguishes itself from hyperplasia, which is tissue enlargement due to an increased number of cells, and atrophy, which is the reduction in cell size or wasting away of tissue. The underlying cellular mechanism involves the increased synthesis of structural proteins and intracellular organelles, typically functioning as an adaptive response to increased functional demand, mechanical stress, or hormonal stimulation. It can be physiological (e.g., skeletal muscle enlargement from weightlifting, or uterine enlargement during pregnancy) or pathological (e.g., left ventricular hypertrophy due to chronic systemic hypertension). The clinically relevant subtypes most commonly encountered in coding include left ventricular hypertrophy (I51.7), benign prostatic hypertrophy/hyperplasia (N40.0), and tonsillar hypertrophy (J35.1). It is commonly confused with a tumor or neoplasm; however, hypertrophy is a regulated, non-neoplastic cellular adaptation to stress, whereas a tumor represents an uncontrolled, independent clonal proliferation of cells.

---

ETYMOLOGY of hypertrophy

greek

Component	Origin	Meaning
hyper-	Greek hyper (ὑπέρ)	“over,” “above,” “excessive” — intensifying prefix denoting excess or exaggeration
troph-	Greek trophē (τροφή), from trephein (τρέφειν)	“nourishment,” “food,” “growth”
-trophy	Greek -trophia (-τροφία)	Noun-forming suffix — “state of nourishment or growth”

The word entered English in the 1830s as hypertrophy (noun), borrowed from French hypertrophie, from Modern Latin, constructed from Greek roots — literally “excessive nourishment or growth.” The adjective form hypertrophic followed shortly after. The root trophē (“nourishment”) connects hypertrophy to the entire -trophy family: atrophy (lack of nourishment/wasting), dystrophy (disordered or defective nourishment/growth), and amyotrophic (pertaining to lack of muscle nourishment). The intensifying prefix hyper- is highly productive in medical terminology, appearing in terms like hypertension, hyperglycemia, and hyperthyroidism.

---

🔀 ALIASES / ALTERNATE TERMS

• Hypertrophic (adjective form — e.g., “hypertrophic cardiomyopathy,” “hypertrophic scar”)
• Enlargement (lay/clinical synonym — frequently used in patient explanations, e.g., “prostate enlargement,” “heart enlargement”)
• Overgrowth (lay synonym — occasionally used to describe hypertrophic bone or tissue changes)
• Ventricular hypertrophy (anatomic subtype — enlargement of the heart ventricles, typically the left, often due to hypertension; I51.7)
• Benign prostatic hypertrophy(BPH) (anatomic subtype — age-related prostate enlargement; N40.x series)
• Tonsillar hypertrophy (anatomic subtype — enlargement of the palatine tonsils causing airway obstruction; J35.1)
• Turbinate hypertrophy (anatomic subtype — enlargement of the nasal conchae causing nasal obstruction; J34.3)
• Compensatory hypertrophy (etiologic subtype — enlargement of one organ/tissue when a paired organ is lost or damaged, e.g., a single remaining kidney)
• Muscular hypertrophy (physiologic subtype — increase in skeletal muscle mass secondary to resistance training)

---

🔗 RELATED TERMS

• Atrophy — the opposite of hypertrophy; the partial or complete wasting away or reduction in size of a body part, organ, tissue, or cell due to decreased cell size.
• Dystrophy — shares the -trophy root; a disorder characterized by defective or abnormal tissue growth and maintenance, often genetic (e.g., Muscular Dystrophy).
• Hyperplasia — closely related adaptive mechanism; an increase in the size of a tissue or organ due to an increase in the number of cells, which frequently occurs concurrently with hypertrophy.
• Cardiomegaly — clinical entity representing an enlarged heart (coded as I51.7); hypertrophy is the primary cellular mechanism driving this enlargement.
• cardiomyopathy — a disease of the heart muscle, a major subtype of which is Hypertrophic Cardiomyopathy (HCM), characterized by pathological thickening of the heart walls.
• Echocardiogram — primary diagnostic imaging procedure used to evaluate cardiac hypertrophy and measure ventricular wall thickness.
• Neoplasia — abnormal and uncontrolled cell growth (tumors); distinctly different from the regulated, stress-responsive nature of hypertrophy.

---

CODING CORNER

🏥 ICD-10-CM CODES

Cardiac Hypertrophy / Enlargement

Code	Description
I51.7	Cardiomegaly (includes Left Ventricular Hypertrophy [LVH] and Right Ventricular Hypertrophy [RVH])
I11.9	Hypertensive heart disease without heart failure (often coded with I51.7 for hypertensive LVH)
I42.1	Obstructive hypertrophic cardiomyopathy
I42.2	Other hypertrophic cardiomyopathy

Respiratory / ENT Hypertrophy

Code	Description
J35.1	Hypertrophy of tonsils
J35.2	Hypertrophy of adenoids
J35.3	Hypertrophy of tonsils with hypertrophy of adenoids
J34.3	Hypertrophy of nasal turbinates

Genitourinary Hypertrophy

Code	Description
N40.0	Benign prostatic hyperplasia without lower urinary tract symptoms
N40.1	Benign prostatic hyperplasia with lower urinary tract symptoms
N90.6	Hypertrophy of vulva

Skin / Integumentary Hypertrophy

Code	Description
L91.0	Hypertrophic scar
L28.0	Lichen simplex chronicus (includes neurodermatitis/hypertrophic dermatitis)

---

🔧 COMMON CPT CODES (Hypertrophy-Related Diagnosis & Treatment)

CPT Code	Description
93306	Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography (diagnostic for LVH)
42820	Tonsillectomy and adenoidectomy; younger than age 12 (treatment for tonsillar/adenoid hypertrophy)
42821	Tonsillectomy and adenoidectomy; age 12 or over
52601	Transurethral electrosurgical resection of prostate, including control of postoperative bleeding, complete (TURP for BPH)
30140	Submucous resection inferior turbinate, partial or complete, any method (treatment for turbinate hypertrophy)

---

⚠️ Coding Note: For inpatient profee and outpatient coding, etiology and associated symptoms are critical for accurate code selection. When coding Left Ventricular Hypertrophy (LVH), if it is due to hypertension, ICD-10-CM guidelines presume a cause-and-effect relationship; you must sequence the hypertensive heart disease (e.g., I11.9) before the LVH code (I51.7) unless the provider explicitly documents that the two conditions are unrelated. An undercoding alert: for Benign Prostatic Hypertrophy/Hyperplasia (BPH), do not simply default to N40.0; review the chart for Lower Urinary Tract Symptoms (LUTS) like retention, hesitancy, or frequency. If LUTS are present, you must use N40.1 and assign additional codes to identify the specific symptoms. Furthermore, in CPT coding for surgical treatments of hypertrophy (like 42820 and 42821 for tonsillectomy), ensure the patient’s exact age is verified, as these procedure codes are strictly age-stratified.

---

DERIVATIONS of hypertrophy

TABLE definition AS Definition
FROM #medterm 
WHERE length(filter(roots, (word) => econtains([[hypertrophy]].roots, word))) > 0 AND file.name != [[hypertrophy]].file.name
SORT file.name ASC

---

Query functionality

TABLE definition AS Definition
FROM #medterm 
WHERE length(filter(definition, (word) => econtains([[hypertrophy]].definition, word))) > 0 AND file.name != [[hypertrophy]].file.name

Med roots Appendix A Prefixes Appendix B Combining Forms Appendix C Suffixes Appendix D Suffix forms